A superior extracellular matrix binding motif to enhance the regenerative activity and safety of therapeutic proteins.

Publication Year: 2023

DOI:
10.1038/s41536-023-00297-0

PMCID:
PMC10202959

PMID:
37217533

Journal Information

Full Title: NPJ Regen Med

Abbreviation: NPJ Regen Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests Monash University has filed for patent protection on the molecular design described herein, and Z.J. and M.M.M. are named as inventors. Z.J. and M.M.M are co-founders of Orio Therapeutics, which entered a license agreement with Monash University to secure the exclusive rights to commercialise the technology. The other authors declare that they have no competing interests."

Evidence found in paper:

"The authors thank Dr. Michael de Veer at the Monash Bioimaging Facility for support with echocardiogram imaging, Ms. Sin Nee Lau for assistance with histology processing, and Ms. Bhavana Nayer for helping with the intramyocardial injections. Biorender.com was used to create some illustrations in the figures. This work was funded in part by the National Health and Medical Research Council (APP1140229 and APP1176213) to M.M.M, the Viertel Charitable Foundation Senior Medical Researcher Fellowship to M.M.M. and the Swiss National Science Foundation (P2ELP3_175071) to Z.J. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025